These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
204 related items for PubMed ID: 6112655
1. The glucoregulatory response to intravenous glucose infusion in normal man: roles of insulin and glucose. Saccà L, Vitale D, Cicala M, Trimarco B, Ungaro B. Metabolism; 1981 May; 30(5):457-61. PubMed ID: 6112655 [Abstract] [Full Text] [Related]
2. Differential effects of insulin on splanchnic and peripheral glucose disposal after an intravenous glucose load in man. Saccà L, Cicala M, Trimarco B, Ungaro B, Vigorito C. J Clin Invest; 1982 Jul; 70(1):117-26. PubMed ID: 6123524 [Abstract] [Full Text] [Related]
8. Prolonged infusion of somatostatin with glucagon replacement increases plasma glucose and glucose turnover in man. Ward WK, Best JD, Halter JB, Porte D. J Clin Endocrinol Metab; 1984 Mar; 58(3):449-53. PubMed ID: 6141177 [Abstract] [Full Text] [Related]
9. Transient hepatic response to glucagon in man: role of insulin and hyperglycemia. Ferrannini E, DeFronzo RA, Sherwin RS. Am J Physiol; 1982 Feb; 242(2):E73-81. PubMed ID: 7039338 [Abstract] [Full Text] [Related]
10. The effect of somatostatin on the hepatic extraction of insulin and glucagon in the anesthetized dog. Ishida T, Röjdmark S, Bloom G, Chou MC, Field JB. Endocrinology; 1980 Jan; 106(1):220-30. PubMed ID: 7349954 [Abstract] [Full Text] [Related]
11. The pancreatic glucagon and C-peptide secretion during hyperinsulinemia in euglycemic glucose clamp with or without somatostatin infusion in normal man. Wu MS, Ho LT. Horm Metab Res; 1987 Jun; 19(6):253-6. PubMed ID: 2887501 [Abstract] [Full Text] [Related]
12. The influence of graded hyperglycemia with and without physiological hyperinsulinemia on forearm glucose uptake and other metabolic responses in man. Jackson RA, Hamling JB, Blix PM, Sim BM, Hawa MI, Jaspan JB, Belin J, Nabarro JD. J Clin Endocrinol Metab; 1986 Sep; 63(3):594-604. PubMed ID: 2874153 [Abstract] [Full Text] [Related]
14. Effect of intermittent endogenous hyperglucagonemia on glucose homeostasis in normal and diabetic man. Rizza R, Verdonk C, Miles J, Service FJ, Gerich J. J Clin Invest; 1979 Jun; 63(6):1119-23. PubMed ID: 447838 [Abstract] [Full Text] [Related]
15. Restoration of stable metabolic conditions during islet suppression in dogs. Bradley DC, Bergman RN. Am J Physiol; 1992 Apr; 262(4 Pt 1):E532-8. PubMed ID: 1348903 [Abstract] [Full Text] [Related]
16. Role of hyperglucagonemia in maintenance of increased rates of hepatic glucose output in type II diabetics. Baron AD, Schaeffer L, Shragg P, Kolterman OG. Diabetes; 1987 Mar; 36(3):274-83. PubMed ID: 2879757 [Abstract] [Full Text] [Related]
17. Adrenergic mechanisms for the effects of epinephrine on glucose production and clearance in man. Rizza RA, Cryer PE, Haymond MW, Gerich JE. J Clin Invest; 1980 Mar; 65(3):682-9. PubMed ID: 6243675 [Abstract] [Full Text] [Related]
18. Role of glucagon, catecholamines, and growth hormone in human glucose counterregulation. Effects of somatostatin and combined alpha- and beta-adrenergic blockade on plasma glucose recovery and glucose flux rates after insulin-induced hypoglycemia. Rizza RA, Cryer PE, Gerich JE. J Clin Invest; 1979 Jul; 64(1):62-71. PubMed ID: 36413 [Abstract] [Full Text] [Related]
19. Mechanisms of epinephrine-induced glucose intolerance in normal humans. Saccà L, Vigorito C, Cicala M, Ungaro B, Sherwin RS. J Clin Invest; 1982 Feb; 69(2):284-93. PubMed ID: 7035494 [Abstract] [Full Text] [Related]
20. The role of glucagon in the pathogenesis of the endogenous hyperglycemia of diabetes mellitus. Sakurai H, Dobbs RE, Unger RH. Metabolism; 1975 Nov; 24(11):1287-97. PubMed ID: 1186499 [Abstract] [Full Text] [Related] Page: [Next] [New Search]